{"count":4,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/b61e96b2-3412-4795-9479-cc82759463cf/","filing_uuid":"b61e96b2-3412-4795-9479-cc82759463cf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b61e96b2-3412-4795-9479-cc82759463cf/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Heather Strawn","dt_posted":"2026-04-16T15:47:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400426042,"url":"https://lda.gov/api/v1/registrants/400426042/","house_registrant_id":null,"name":"LUNDBECK LLC","description":"Specialty and Central Nervous System Bio-pharmaceutical manufacturing","address_1":"1455 Pennsylvania Ave NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HEATHER STRAWN","contact_telephone":"+1 202-412-1563","dt_updated":"2026-07-29T13:14:27.156557-04:00"},"client":{"id":190625,"url":"https://lda.gov/api/v1/clients/190625/","client_id":12,"name":"LUNDBECK LLC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to Pharmacy Benefit Managers - H.R.4317, PBM Reform Act of 2025; H.R.6703, Lower Health Care Premiums for All Americans Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Pediatric rare diseases - H.R. 1262 & S. 932, Give Kids a Chance Act of 2025 Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues pertaining to the 340B Drug Discount Program - H.R. 5256, 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to the implementation of the Inflation Reduction Act of 2022 - H.R. 6166, Lowering Drug Costs for American Families Act Issues pertaining to Pharmacy Benefit Managers - S.3345, PBM Price Transparency and Accountability Act; H.R.4317, PBM Reform Act of 2025 Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 and FY2027 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 7837, Most Favored Patient Act of 2026 Issues pertaining to migraine screening for women in Medicare - FY 2026 and FY2027 Labor-HHS Appropriations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on pharmaceutical products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7c80590e-8829-41cf-a635-db969186403f/","filing_uuid":"7c80590e-8829-41cf-a635-db969186403f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7c80590e-8829-41cf-a635-db969186403f/print/","filing_document_content_type":"text/html","income":null,"expenses":"180000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Heather Strawn","dt_posted":"2026-07-16T11:11:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400426042,"url":"https://lda.gov/api/v1/registrants/400426042/","house_registrant_id":null,"name":"LUNDBECK LLC","description":"Specialty and Central Nervous System Bio-pharmaceutical manufacturing","address_1":"1455 Pennsylvania Ave NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HEATHER STRAWN","contact_telephone":"+1 202-412-1563","dt_updated":"2026-07-29T13:14:27.156557-04:00"},"client":{"id":190625,"url":"https://lda.gov/api/v1/clients/190625/","client_id":12,"name":"LUNDBECK LLC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025; H.R. 9504, Tax Exempt Hospital Transparency Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Issues related to DTC advertising regulations Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Issues pertaining to prior authorization - HR 9396, Prior Authorization Accountability Act Issues pertaining to transparency - HR 9393, Lower Costs, More Transparency Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues pertaining to the implementation of the Inflation Reduction Act of 2022 - H.R. 6166, Lowering Drug Costs for American Families Act Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 and FY2027 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 7837, Most Favored Patient Act of 2026 Issues pertaining to migraine screening for women in Medicare - FY 2026 and FY2027 Labor-HHS Appropriations Issues pertaining to prior authorization - HR 3514, Improving Seniors Timely Access to Care Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on pharmaceutical products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e9b091ef-93a6-4072-8c95-48f7a8f96567/","filing_uuid":"e9b091ef-93a6-4072-8c95-48f7a8f96567","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/e9b091ef-93a6-4072-8c95-48f7a8f96567/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Heather Strawn","dt_posted":"2026-10-15T10:12:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400426042,"url":"https://lda.gov/api/v1/registrants/400426042/","house_registrant_id":null,"name":"LUNDBECK LLC","description":"Specialty and Central Nervous System Bio-pharmaceutical manufacturing","address_1":"1455 Pennsylvania Ave NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HEATHER STRAWN","contact_telephone":"+1 202-412-1563","dt_updated":"2026-07-29T13:14:27.156557-04:00"},"client":{"id":190625,"url":"https://lda.gov/api/v1/clients/190625/","client_id":12,"name":"LUNDBECK LLC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-03-01"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on pharmaceutical products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025; H.R. 9504, Tax Exempt Hospital Transparency Act; S.5244, SUSTAIN 340B Act; H.R.9599, SECURE 340B Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Issues related to DTC advertising regulations Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Issues pertaining to prior authorization - HR 9396, Prior Authorization Accountability Act Issues pertaining to transparency - HR 9393, Lower Costs, More Transparency Act Issues pertaining to Pediatric Priority Review Voucher program at the FDA - H.R.10359, Priority for Pediatric Cures Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues pertaining to the implementation of the Inflation Reduction Act of 2022 - H.R. 6166, Lowering Drug Costs for American Families Act Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 and FY2027 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 7837, Most Favored Patient Act of 2026 Issues pertaining to migraine screening for women in Medicare - FY 2026 and FY2027 Labor-HHS Appropriations Issues pertaining to prior authorization - HR 3514, Improving Seniors Timely Access to Care Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3bdb04b8-0bdd-4f34-9450-210c4822fd59/","filing_uuid":"3bdb04b8-0bdd-4f34-9450-210c4822fd59","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/3bdb04b8-0bdd-4f34-9450-210c4822fd59/print/","filing_document_content_type":"text/html","income":null,"expenses":"250000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kira Peterson","dt_posted":"2026-10-20T14:31:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"409 12th Street, SW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":400578740,"url":"https://lda.gov/api/v1/registrants/400578740/","house_registrant_id":null,"name":"AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS","description":"Medical Specialty Organization","address_1":"409 12th Street, SW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RACHEL TETLOW","contact_telephone":"+1 202-863-2534","dt_updated":"2026-07-30T10:48:37.231062-04:00"},"client":{"id":193054,"url":"https://lda.gov/api/v1/clients/193054/","client_id":12,"name":"AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-04-19"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Womens health research (general); Centers for Disease Control and Prevention (CDC); National Institutes of Health (NIHNIH Office of Research on Womens Health; Health Resources and Services Administration (HRSA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Safe Motherhood and Infant Health Program (CDC); IHS funding (general); National Center for Chronic Disease Prevention and Health Promotion (CDC); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC); inclusion of pregnant and lactating people in clinical trials (general); Congressionally Directed Medical Research Program (CDMRP); Title X family planning program; Title V Maternal and Child Health Block Grant; Pregnancy Risk Assessment Monitoring System (CDC); Teaching Health Center Graduate Medical Education Program (THCGME); Healthy Start; National Maternal Mental Health Hotline; maternal mental health programs; Alliance for Innovation on Maternal Health (AIM); menopause education; OMB Regulation for Federal Financial Assistance (OMB-2026-0034-0001); Dr. Lorna Breen Health Care Provider Protection Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64197,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"TETLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"FY27 National Defense Authorization Act; IVF coverage for servicemembers and dependents (general)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; implementation of Sec. 6501 of P.L. 119-75, Preventing Maternal Deaths Reauthorization Act; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 7973, Momnibus Act H.R. 9441, SAFE Training for OBGYNs Act; H.R. 9090/S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act; H.R. 10600, Abortion is Health Care Everywhere Act; S. ____, Know Your Risk Act; S. 3254/H.R. 6238, NIH IMPROVE Act; H.R. 9946, Equity in STI Testing Act; H.R. 3387, No Surprise Bills for New Moms Act; H.R. 9842, State Offices of Womens Health Support and Expansion Act; H.R. 2028/S. 942, REDI Act; H.R. 5536, HEADACHE Act; H.Res.739/S.Res.401, National Stillbirth Prevention & Awareness Day Resolution; S. ____, Jeanette Acosta Invest in Womens Health Act; HR.____ /S. 5554, Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act; H.R. ____, Improving Access to WIC Act; H.R. ____/S. ____, Support Through Loss Act; H.R. 6468/S. 5232, Rural Residency Planning and Development Act; H.R. _____/S. 4445, Right to IVF Act; S. 4494, maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); inclusion of pregnant and lactating women in clinical trials (general); NIH/NICHD womens health research (general); clinical research workforce development (general); access to fertility services and treatments (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); OMB Regulation for Federal Financial Assistance (OMB-2026-0034-0001); estradiol patch shortage (general); menopause education (general); risk-reducing salpingectomy (general).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64197,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"TETLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Treatment of pregnant and postpartum people in immigration detention (general); access to medical care in immigration detention (general); H.R. 1061/S. 455, Protecting Sensitive Locations Act; H-1B and J-1 visa delays/disruptions for physicians and trainees (general); H.R. 7961, H-1Bs for Physicians and the Healthcare Workforce Act; H-1B Cap Subject Application Fee","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Physician payment under Medicare (general); Medicare Physician Fee Schedule Efficiency Adjustment (general); Graduate medical education (general); S.1816/H.R. 3514, Improving Seniors Timely Access to Care Act of 2025; Prior authorization in Medicare (general); Medicaid (general); Physician payment under Medicaid (general); Medicaid work requirements (general); CMS billing and coding procedures (general); preserving postpartum Medicaid extension (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; telehealth (general); H.R. 7520, Efficiency Adjustment Delay Act; H.R. 8163, Provider Reimbursement Stability Act; FMAP for Puerto Rico; unbundling of obstetric codes in Medicare; H.R. 4731/S. 2439, Resident Physician Shortage Reduction Act; H.R. 9693, Patients First Act; S. 5037, MediKids Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64197,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"TETLOW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76425,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"SATTERFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139300,"prefix":"ms","prefix_display":"MS.","first_name":"TAYLOR","nickname":null,"middle_name":null,"last_name":"PLATT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142986,"prefix":"mrs","prefix_display":"MRS.","first_name":"ERIN","nickname":null,"middle_name":"LAMBIE","last_name":"ALSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Abortion access at the VA (general); S. 1320, Servicewoman and Veterans Menopause Research Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146809,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BOGDAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139414,"prefix":"ms","prefix_display":"MS.","first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"LAUER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144986,"prefix":null,"prefix_display":null,"first_name":"LILLIE","nickname":null,"middle_name":null,"last_name":"HEYMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}